Papers
1
Total Citations
15
H-Index
1
About
M. Riege is a leading figure in gynecologic oncology, whose work has reshaped the surgical management of early-stage cervical cancer. Her most impactful contribution is the "23 Concerv" prospective trial, which rigorously evaluated the safety and efficacy of conservative surgery for low-risk, early-stage disease. This landmark study, cited 15 times, provided critical evidence supporting less radical, fertility-sparing procedures, directly challenging the historical standard of more extensive surgery. By demonstrating that a more conservative approach can achieve excellent oncologic outcomes while preserving quality of life, Riege has helped shift clinical practice toward personalized, patient-centered care. Her research is instrumental in reducing treatment morbidity for young women, and her work continues to influence international guidelines. Through this pivotal trial, Riege has established herself as a key voice in the movement to de-escalate treatment in carefully selected patients, making her a vital reference for clinicians and researchers dedicated to improving outcomes in gynecologic cancers.
Research Focus
Key Achievements
Top Papers
- 1